The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy

2013 ◽  
Vol 21 (3) ◽  
pp. 208-215 ◽  
Author(s):  
M. Backx ◽  
A. Lewszuk ◽  
J. R. White ◽  
J. Cole ◽  
A. Sreedharan ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Treatment Failure ◽  
Resource Use ◽  
Virological Response ◽  
Response To Therapy ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Cost Of Treatment ◽  
The Cost

scholarly journals Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure

Hepatology ◽  
2018 ◽  
Vol 67 (4) ◽  
pp. 1253-1260 ◽  
Author(s):  
Fred Poordad ◽  
Stanislas Pol ◽  
Armen Asatryan ◽  
Maria Buti ◽  
David Shaw ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Treatment Failure ◽  
Antiviral Treatment ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Direct Acting Antiviral ◽  
Direct Acting

Rapid virological response in hepatitis C virus genotype 1 and early ribavirin exposure

Hepatology ◽  
2008 ◽  
Vol 48 (2) ◽  
pp. 692-693
Author(s):  
Chia-Yen Dai ◽  
Wan-Long Chuang ◽  
Jee-Fu Huang ◽  
Ming-Yen Hsieh ◽  
Ming-Lung Yu
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virological Response ◽  
Rapid Virological Response ◽  
Genotype 1 ◽  
Virus Genotype

scholarly journals Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1

Hepatology ◽  
2011 ◽  
Vol 53 (4) ◽  
pp. 1109-1117 ◽  
Author(s):  
William Sievert ◽  
Gregory J. Dore ◽  
Geoffrey W. McCaughan ◽  
Motoko Yoshihara ◽  
Darrell H. Crawford ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virological Response ◽  
Hemoglobin Concentration ◽  
Pegylated Interferon ◽  
Genotype 1 ◽  
Virus Genotype
Sign in / Sign up

Export Citation Format

Share Document